The Addition of Inotuzumab Ozogamicin to Hyper-CVAD Plus Blinatumomab Further Improves Outcomes in Patients with Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia: Updated Results from a Phase II Study

Authors :: Nicholas Short
Elias Jabbour
Farhad Ravandi
Musa Yilmaz
Tapan M. Kadia
Philip A. Thompson
Xuelin Huang
Marina Konopleva
Alessandra Ferrajoli
Nitin Jain
Koji Sasaki
Walid Macaron
Yesid Alvarado
Gautam Borthakur
Courtney D. DiNardo
Maro Ohanian
Steven M. Kornblau
Min Zhao
Monica Kwari
Jennifer Thankachan
Christopher Loiselle
Ricardo Delumpa
Rebecca Garris
Hagop Kantarjian
Source :: Blood. 140:8966-8968
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Full Text Access

Tools